9 Nat Mur

9 Nat Mur

HOMEOFORCE TISSUE SALTS 9 NAT MUR is known to regulate the body's fluid balance and is essential for healthy skin and mucous membranes. It is found in the blood and lymphatic system.

It is indicated for Dry Skin, Runny Nose & Water Retention

Available At:

DischemMopani Pharmacy

Dosage:

  • adults: 1 tablet
  • children: Half a tablet
  • infants: A quarter tablet, crushed and dissolved in water.
  • general: Dissolve tablet(s) under the tongue 3 times daily.
  • acute: Every half an hour (up to 12 times a day) or until improvement of symptoms, then resume general dosing.

Ingredients:

  • Each tablet contains:
  • Sodium chloride (Natrum muriaticum)
  • Inactive ingredients:
  • Lactose and magnesium stearate
  • Contains sugar: Lactose 0,24 g/tablet
  • Suitable for vegetarians.

Contraindications:

  • Do not use HOMEOFORCE TISSUE SALTS 9 NAT MUR if you are hypersensitive (allergic) to any of the ingredients.

Warnings & Special Precautions

If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy.

Do not exceed recommended dosage(s) unless on the advice of a healthcare practitioner. Contains lactose. Patients with the rare hereditary conditions of galactose intolerance e.g. galactosaemia, Lapp lactase deficiency or glucose-galactose malabsorption should not take HOMEOFORCE TISSUE SALTS 9 NAT MUR.

Contains lactose which may have an effect on the glycaemic control of patients with diabetes mellitus. This unregistered medicine has not been evaluated by SAHPRA for its quality, safety or intended use. Tissue Salts are safe in pregnancy and lactation; however, you should always consult with your healthcare provider.

Logo

ASCENDIS CONSUMER BRANDS (PTY) LTD. Reg-Nr. 2013/195936/07 | VAT 4460264361

© HOMEOFORCE 2026. All Rights Reserved

ASCENDIS CONSUMER BRANDS DIVISION
Ascendis Logo
Follow us on social media for the latest updates
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.
For full prescribing information, refer to the Professional Information approved by the medicines regulatory authority.